SMAD4 and gastric cancer: Zheng et al37 showed that endogenous miR‐558 decreased the binding of Smad4 to HPSE, activated the transcription and expression of HPSE, and promoted tumorigenesis and invasion of gastric cancer cells both in vitro and in vivo.